The store will not work correctly when cookies are disabled.
We use cookies for optimal website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.
Allow cookies Deny
CAS NO.: 2491753-71-8;5-bromo-1-methyl-2',3',5',6'-tetrahydrospiro[indoline-3,4'-pyran]-2-one. PROPERTIES: This brominated spiro-heterocycle presents as a white crystalline solid with a molecular weight of approximately 351.2 g/mol. The 5-bromo-1-methyl-2',3',5',6'-tetrahydrospiro[indoline-3,4'-pyran]-2-one combines a bromine substituent with a spiro-fused indoline and pyran framework. It exhibits limited aqueous solubility but dissolves well in polar aprotic solvents like DMSO and THF. Stability characterization reveals vulnerability to acid-catalyzed spiro-bond cleavage and base-promoted deprotonation of the lactone carbonyl, necessitating storage at 2-8 degree Celsius in sealed glass containers. Handlers should use powder hoods with HEPA filtration and wear cut-resistant gloves during handling. Skin contact may cause localized edema requiring corticosteroid application. Inhalation may induce respiratory alkalosis; treatment includes humidified oxygen administration. Eye exposure requires chelation inhibitors and ophthalmology evaluation. Waste should be hydrolyzed with dilute acid prior to disposal. APPLICATIONS: The 5-bromo-1-methyl-2',3',5',6'-tetrahydrospiro[indoline-3,4'-pyran]-2-one serves as a key intermediate in the synthesis of various pharmaceuticals. Its spiro-fused framework provides opportunities for constructing complex alkaloids and receptor-targeted molecules. Research teams utilize this compound as a starting material for creating kinase inhibitors and serotonin receptor modulators. The bromine substituent enhances metabolic resistance in resulting drug candidates. Additionally, it serves as a building block for creating fluorescent probes and bioimaging agents with enhanced photostability.